News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KineMed, Inc. to Discuss New Applications of Biomarkers for Neurodegenerative Therapeutics at the 7th Annual Neurotech Investing & Partnering Conference


5/15/2012 10:21:09 AM

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed Inc. (www.kinemed.com) announced today that David Fineman, KineMed’s President & CEO, will be a panelist in the session titled “Movement Disorders: Parkinson’s, Huntington’s, and ALS” being held at the 7th annual Neurotech Investing & Partnering Conference at 3:30 PM EST May 21st at the Intercontinental Hotel Boston.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES